JP Morgan Chase’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
VCM
VPM
JP Morgan Chase's DXCM Position: Q1 2026 in Review
JP Morgan Chase reduced its DexCom (DXCM) stake by 3.5% in Q1 2026, selling an estimated $15.1M and leaving 5,999,470 shares worth $371M. The position accounts for 0.02% of the portfolio, ranked #491.
JP Morgan Chase first reported a position in DXCM in Q2 2013 and has held it in 50 quarters since. The position peaked at $1.64B in Q3 2021. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- JP Morgan Chase held 5,999,470 shares of DexCom worth $371M as of Q1 2026.
- JP Morgan Chase sold 216,931 DexCom shares in Q1 2026, an estimated $15.1M.
- DexCom made up 0.02% of JP Morgan Chase's portfolio in Q1 2026, its #491 holding.
- JP Morgan Chase first reported a position in DexCom in Q2 2013 and has held it in 50 quarters since.
- JP Morgan Chase's DexCom position peaked at $1.64B in Q3 2021.
- 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.